Ohio Code § 4725.01

§ 4725.01.

As used in this chapter: (A) The “ practice of optometry ” means all of the following: (1) The application of optical principles, through technical methods and devices, in

the examination of human eyes for the purpose of ascertaining departures from the

normal, measuring their functional powers, adapting optical accessories for the aid

thereof, and detecting ocular abnormalities that may be evidence of disease, pathology,

or injury; (2) Employing, applying, administering, and prescribing instruments, devices, and procedures,

other than invasive procedures, for purpose 1 of examination, investigation, diagnosis, treatment, or prevention of any disease,

injury, or other abnormal condition of the visual system; (3) Employing, applying, administering, and prescribing topical ocular pharmaceutical

agents; (4) Employing, applying, administering, and prescribing therapeutic pharmaceutical agents; (5) Assisting an individual in determining the individual's blood glucose level by using

a commercially available glucose-monitoring device.  Nothing in this section precludes a licensed optometrist from using any particular

type of commercially available glucose-monitoring device; (6) Designing, fabricating, and fitting artificial eyes or prostheses associated with

the appearance or function of the human eye. (B) “ Topical ocular pharmaceutical agent ” means a drug or dangerous drug that is a topical drug and used for evaluative purposes

in the practice of optometry or for purposes of examination, investigation, diagnosis,

treatment, or prevention of any disease, injury, or other abnormal condition of the

visual system. (C) “ Therapeutic pharmaceutical agent ” means a drug or dangerous drug that is used for examination, investigation, diagnosis,

treatment, or prevention of any disease, injury, or other abnormal condition of the

visual system in the practice of optometry by a licensed optometrist, and is any of

the following: (1) An oral drug or dangerous drug in one of the following classifications: (a) Anti-infectives, including antibiotics, antivirals, antimicrobials, and antifungals; (b) Anti-allergy agents; (c) Antiglaucoma agents; (d) Analgesics, including only analgesic drugs that are available without a prescription,

analgesic drugs or dangerous drugs that require a prescription but are not controlled

substances, and, to the extent authorized by the state vision professionals board

in rules adopted under section 4725.091 of the Revised Code , analgesic controlled substances; (e) Anti-inflammatories, excluding all drugs or dangerous drugs classified as oral steroids

other than methylpredisolone, except that methylpredisolone may be used only if it

is prescribed under all of the following conditions: (i) For use in allergy cases; (ii) For use by an individual who is eighteen years of age or older; (iii) On the basis of an individual's particular episode of illness; (iv) In an amount that does not exceed the amount packaged for a single course of therapy. (2) Epinephrine administered by injection to individuals in emergency situations to counteract

anaphylaxis or anaphylactic shock.  Notwithstanding any provision of this section to the contrary, administration of

epinephrine in this manner does not constitute performance of an invasive procedure. (3) An oral drug or dangerous drug that is not included under division (C)(1) of this

section, if the drug or dangerous drug is approved, exempt from approval, certified,

or exempt from certification by the federal food and drug administration for ophthalmic

purposes and the drug or dangerous drug is specified in rules adopted by the board

under section 4725.09 of the Revised Code . (D) “Controlled substance” has the same meaning as in section 3719.01 of the Revised Code . (E) “Drug” and “dangerous drug” have the same meanings as in section 4729.01 of the Revised Code . (F) “ Invasive procedure ” means any procedure that involves cutting or otherwise infiltrating human tissue

by mechanical means including surgery, laser surgery, ionizing radiation, therapeutic

ultrasound, administering medication by injection, or the removal of intraocular foreign

bodies. (G) “ Visual system ” means the human eye and its accessory or subordinate anatomical parts. (H) “ Certificate of licensure ” means a certificate issued by the board under section 4725.13 of the Revised Code authorizing the holder to engage in the practice of optometry. 1

 Prior and current versions differ;  although no amendment to this language was indicated

in 2008 S 245 or subsequent legislation, “purpose” appeared as “purposes” in 2007

H 149.